YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Complete Genomics and China's Ulterior Motives


December 13, 2012 | Michael Wessel and Larry Wortzel, congressionally-appointed members of the U.S.-China Economic and Security Review Commission, recommend the utmost scrutiny of the BGI-Complete Genomics deal. It's not just future genomic medicine that's at stake, but "the building blocks of 21st-century bioweapons." Mercury News
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.